Louna Blasco

I gaduated from the Université de Technologie de Compiègne with an Biological Engineering degree. I had the opportunity to complete my final-year project working on an organ-on-a-chip to model Drug-Induced-LIver-Injury. Driven by a strong interest in translational biology, I am passionate about connecting technological innovations with real-world applications in terms of human health and bioethics.

Eager to continue working in this dynamic field, I joined the FEMTO-ST Institute in February 2025, as a PhD student involved in the BioImp project. My research focuses on the development of a micro-physiological system to model human metastatic tissues as a novel platform to evaluate anti-cancer biodrug responses. Specifically, I aim to replicate the complexity of the tumor microenvironment in colorectal cancer liver metastasis, including vascularization, cell–cell interactions, and drug delivery mechanisms.

As part of this study, experiments with an innovative anti-cancer immunotherapy based on lymphocytes will be conducted. Quantitative outputs will be partially assessed using biosensors developed in parallel by a postdoctoral researcher. Ultimately, the goal is to evaluate the potential of this system as an ethical and effective alternative to animal models for preclinical testing.